| Nicholas Isaac Key, | |
|
6400 N Santa Fe Ave Ste B, Oklahoma City, OK 73116-9126 | |
| (405) 840-2903 | |
| (405) 840-3256 |
| Full Name | Nicholas Isaac Key |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 6400 N Santa Fe Ave Ste B, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891261806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5261 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Isaac Key, 13709 Pennyworth Dr, Yukon, OK 73099-1346 Ph: (580) 216-0766 | Nicholas Isaac Key, 6400 N Santa Fe Ave Ste B, Oklahoma City, OK 73116-9126 Ph: (405) 840-2903 |
News Archive
Sen. Ted Cruz, R-Texas, criticizes the pending immigration bill and health law while Medicare observation care and audits are hot topics during a Senate Finance Committee hearing. Also in the news, Sen. Charles Grassley, R-Iowa, talks about hospital CEO pay. In addition, he and Sen. Ron Wyden, D-Ore., push to open the Medicare claims payment database.
Today's early morning highlights from major news organizations, including a number of stories detail health law implementation developments.
Medwell Capital Corp. today announced that it has committed to invest up to $2,000,000 in Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately-held, clinical-stage company developing a treatment for dry eye disease. Medwell Capital participated in a Series B equity financing with existing Mimetogen investors, iNovia Capital, MSBi Valorisation and VIMAC Milestone Medica.
An international research team formed by a University of Cincinnati cancer researcher has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP, an energy source that fuels the uncontrolled growth of cancer cells. The research underscores the enzyme's potential to become a therapeutic target for future cancer drugs.
As a result of the ongoing pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, the coronavirus disease 2019 (COVID-19), the global public health at risk has never been more dire.
› Verified 6 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |